Validation of Prediction Models for Mismatch Repair Gene Mutations in Koreans
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Lynch syndrome, the commonest hereditary colorectal cancer syndrome, is caused by germline mutations in mismatch repair (MMR) genes. Three recently developed prediction models for MMR gene mutations based on family history and clinical features (MMRPredict, PREMM1,2,6, and MMRPro) have been validated only in Western countries. In this study, we propose validating these prediction models in the Korean population. Materials and Methods We collected MMR gene analysis data from 188 individuals in the Korean Hereditary Tumor Registry. The probability of gene mutation was calculated using three prediction models, and the overall diagnostic value of each model compared using receiver operator characteristic (ROC) curves and area under the ROC curve (AUC). Quantitative test characteristics were calculated at sensitivities of 90%, 95%, and 98%. Results Of the individuals analyzed, 101 satisfied Amsterdam criteria II, and 87 were suspected hereditary nonpolyposis colorectal cancer. MMR mutations were identified in 62 of the 188 subjects (33.0%). All three prediction models showed a poor predictive value of AUC (MMRPredict, 0.683; PREMM1,2,6, 0.709; MMRPro, 0.590). Within the range of acceptable sensitivity (> 90%), PREMM1,2,6 demonstrated higher specificity than the other models. Conclusion In the Korean population, overall predictive values of the three models (MMRPredict, PREMM1,2,6, MMRPro) for MMR gene mutations are poor, compared with their performance in Western populations. A new prediction model is therefore required for the Korean population to detect MMR mutation carriers, reflecting ethnic differences in genotype-phenotype associations.
Abstract
Purpose Lynch syndrome, the commonest hereditary colorectal cancer syndrome, is caused by germline mutations in mismatch repair (MMR) genes. Three recently developed prediction models for MMR gene mutations based on family history and clinical features (MMRPredict, PREMM1,2,6, and MMRPro) have been validated only in Western countries. In this study, we propose validating these prediction models in the Korean population. Materials and Methods We collected MMR gene analysis data from 188 individuals in the Korean Hereditary Tumor Registry. The probability of gene mutation was calculated using three prediction models, and the overall diagnostic value of each model compared using receiver operator characteristic (ROC) curves and area under the ROC curve (AUC). Quantitative test characteristics were calculated at sensitivities of 90%, 95%, and 98%. Results Of the individuals analyzed, 101 satisfied Amsterdam criteria II, and 87 were suspected hereditary nonpolyposis colorectal cancer. MMR mutations were identified in 62 of the 188 subjects (33.0%). All three prediction models showed a poor predictive value of AUC (MMRPredict, 0.683; PREMM1,2,6, 0.709; MMRPro, 0.590). Within the range of acceptable sensitivity (> 90%), PREMM1,2,6 demonstrated higher specificity than the other models. Conclusion In the Korean population, overall predictive values of the three models (MMRPredict, PREMM1,2,6, MMRPro) for MMR gene mutations are poor, compared with their performance in Western populations. A new prediction model is therefore required for the Korean population to detect MMR mutation carriers, reflecting ethnic differences in genotype-phenotype associations.
참고문헌 (25)
- Rustgi AK, "The genetics of hereditary colon cancer", Genes Dev, 21, pp.2525~2538 (2007)
- Lindor NM, "Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency : familial colorectal cancer type X", JAMA, 293, pp.1979~1985 (2005)
- Mensenkamp AR, "Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatchrepair deficiency in Lynch syndrome-like tumors", Gastroenterology, 146, pp.643~646 (2014)
- Bosman FT, "WHO classification of tumours of the digestive system" (2010), IARC Press
- Kastrinos F, "Prediction models in Lynch syndrome", Fam Cancer, 12, pp.217~228 (2013)
- Monzon JG, "Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer", Int J Cancer, 126, pp.930~939 (2010)
- Vasen HF, "New clinical criteria for hereditary nonpolyposis colorectal cancer(HNPCC, Lynch syndrome)proposed by the International Collaborative group on HNPCC", Gastroenterology, 116, pp.1453~1456 (1999)
- Umar A, "Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer(Lynch syndrome)and microsatellite instability", J Natl Cancer Inst, 96, pp.261~268 (2004)
- Perez-Carbonell L, "Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer", Gut, 61, pp.865~872 (2012)
- Parsons MT, "Correlation of tumour BRAF mutations and MLH1methylation with germline mismatch repair(MMR)gene mutation status : a literature review assessing utility of tumour features for MMR variant classification", J Med Genet, 49, pp.151~157 (2012)
- Pouchet CJ, "A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers", Ann Oncol, 20, pp.681~688 (2009)
- Barnetson RA, "Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer", N Engl J Med, 354, pp.2751~2763 (2006)
- Chen S, "Prediction of germline mutations and cancer risk in the Lynch syndrome", JAMA, 296, pp.1479~1487 (2006)
- Kastrinos F, "The PREMM1, 2, 6 model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history", Gastroenterology, 140, pp.73~81 (2011)
- Green RC, "Prediction of Lynch syndrome in consecutive patients with colorectal cancer", J Natl Cancer Inst, 101, pp.331~340 (2009)
- Balmana J, "Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients", J Med Genet, 45, pp.557~563 (2008)
- Khan O, "Performance of Lynch syndrome predictive models in a multi-center US referral population", Am J Gastroenterol, 106, pp.1822~1827 (2011)
- Tresallet C, "Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome", Int J Cancer, 130, pp.1367~1377 (2012)
- Kastrinos F, "Comparison of the clinical prediction model PREMM(1, 2, 6)and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer", Gut, 62, pp.272~279 (2013)
- Shin YK, "Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families", Hum Mutat, 24, pp.351~ (2004)
- Oh JR, "Microsatellite instability testing in Korean patients with colorectal cancer", Fam Cancer, 11, pp.459~466 (2012)
- De Jesus-Monge WE, "Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico", Fam Cancer, 9, pp.155~166 (2010)
- Park JG, "Suspected HNPCC and Amsterdam criteria II : evaluation of mutation detection rate, an international collaborative study", Int J Colorectal Dis, 17, pp.109~114 (2002)
- Steyerberg EW, "Assessing the performance of prediction models : a framework for traditional and novel measures", Epidemiology, 21, pp.128~138 (2010)
- Win AK, "Criteria and prediction models for mismatch repair gene mutations : a review", J Med Genet, 50, pp.785~793 (2013)